Medicine & Pharmaceuticals 

CAGE Bio Reports Strong Results from its Phase 2b Atopic Dermatitis Trial

CAGE Bio, a biotechnology company advancing ionic liquid–based therapies for immune-mediated skin diseases, today announced positive topline results from its double-blinded, Phase 2b dose-ranging trial of CGB-500 in...

CAGE Bio Reports Strong Results from its Phase 2b Atopic Dermatitis Trial
IDEOlogy Health Lands on Prestigious Inc. 5000 List of Fastest-Growing Private Companies for Second Consecutive Year

IDEOlogy Health, which is leading the change in how healthcare professionals connect and stay up to date on the latest advancements in medicine, was named to the 2025 Inc. 5000, the publication's annual list of the...

IDEOlogy Health Lands on Prestigious Inc. 5000 List of Fastest-Growing Private Companies for Second Consecutive Year
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September...

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 9:15 a.m. ET on September 9, 2025. Peter Griffith, executive vice president and chief financial officer at Amgen, and Kave...

AMGEN TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE
ZERO Prostate Cancer Launches National 2025 Run/Walk Series to Unite Communities and Save Lives

As National Prostate Cancer Awareness Month gets underway, ZERO Prostate Cancer (ZERO), the nation's leading prostate cancer organization, is proud to launch its 2025 Run/Walk Series, a coast-to-coast movement uniting...

ZERO Prostate Cancer Launches National 2025 Run/Walk Series to Unite Communities and Save Lives
Steven Mickelsen, MD, Launches Del Medtech to Expand Pulsed Field Ablation Beyond the Heart

Electrophysiologist and pulsed field ablation (PFA) pioneer Steven Mickelsen, MD today announced the launch of Del Medtech Inc., a seed-stage medical device company with a mission to advance minimally invasive ablation...

Steven Mickelsen, MD, Launches Del Medtech to Expand Pulsed Field Ablation Beyond the Heart
RIVANNA awarded $2.21 million NIH grant to develop pediatric lumbar puncture ultrasound guidance system

RIVANNA®, developers of world-first imaging-based medical technologies, has been awarded a $2.21 million Small Business Innovation Research (SBIR) Direct to Phase II (R44) grant from the National Cancer Institute (NCI) of...

RIVANNA awarded $2.21 million NIH grant to develop pediatric lumbar puncture ultrasound guidance system
Coastal Orthopedics & Sports Medicine Selects DeliverHealth's InstaNote to Streamline Documentation in NextGen

DeliverHealth, the leader in AI-powered clinical documentation, today announced that Coastal Orthopedics and Sports Medicine, serving Sarasota-Manatee counties on Florida's West Coast has implemented eSOne™ InstaNote...

Coastal Orthopedics & Sports Medicine Selects DeliverHealth's InstaNote to Streamline Documentation in NextGen
FDA grants HERNEXEOS® Breakthrough Therapy Designation for first line use in HER2 (ERBB2)-mutant advanced NSCLC

Boehringer Ingelheim today announced HERNEXEOS® (zongertinib tablets) has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for first-line treatment of adult patients with...

FDA grants HERNEXEOS® Breakthrough Therapy Designation for first line use in HER2 (ERBB2)-mutant advanced NSCLC
AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

AbbVie (NYSE: ABBV) today announced updated results from the Phase 2 EPCORE® NHL-6 trial (NCT05451810) evaluating the feasibility of dosing and monitoring patients in the outpatient setting for the first full dose of...

AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Westside Children's Therapy Appoints Sarah Trautman as Chief Clinical Officer

Westside Children's Therapy, a leading pediatric therapy provider in the Chicagoland region, has named Sarah Trautman, MA, MCBA, as Chief Clinical Officer. A nationally respected leader in applied behavior analysis...

Westside Children's Therapy Appoints Sarah Trautman as Chief Clinical Officer
Ultra Maritime Opens London Facility Dedicated to Bringing Anti-Submarine Warfare Solutions to Global Allied Navies

Today, Ultra Maritime officially opened its new integrated design and manufacturing center in London – Greenford, UK, hosting the right honourable Maria Eagle MP for a ribbon cutting ceremony and tour. Located just 10...

Ultra Maritime Opens London Facility Dedicated to Bringing Anti-Submarine Warfare Solutions to Global Allied Navies
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints

Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo™ robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures....

Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Sempre Health launches in-store savings notifications for patients, bringing discounts right to the pharmacy counter

Sempre Health, a leader in behavior-based medication affordability, today announced a new, innovative way to redefine the pharmacy visit experience. Patients can now receive instant notifications that prompt them to refill...

Sempre Health launches in-store savings notifications for patients, bringing discounts right to the pharmacy counter
Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site

Cardinal Health (NYSE: CAH) announced the opening of its newest distribution center in Fort Worth, Texas – a facility solely dedicated to the at-Home Solutions business, a leading medical supplies provider that serves more...

Cardinal Health at-Home Solutions opens Texas distribution center; announces plans for new California site
Over Half of American Parents of Minors are Worried About Missing the Warning Signs of Potential Drug Use by Their Children, New National Survey Reveals

A majority of U.S. parents with children younger than age 18 (51%) are concerned about missing the warning signs of potential drug use by their kids, according to a new survey conducted by The Harris Poll, among over 1,200...

Over Half of American Parents of Minors are Worried About Missing the Warning Signs of Potential Drug Use by Their Children, New National Survey Reveals
Healthcare2U: New Legislation Paves the Way for HSA-Compatible Direct Primary Care

In a landmark move for the health benefits landscape, H.R.?1 / Public Law 119-21 will allow Health Savings Account (HSA) contributions to be used for Direct Primary Care (DPC) memberships and related out-of-pocket costs...

Healthcare2U: New Legislation Paves the Way for HSA-Compatible Direct Primary Care
Assort Health Announces Inaugural Assort Ascend Customer Summit to Support Healthcare Leaders in Navigating AI Agent Transformation for Patient Engagement and Provider Operations

Assort Health, the most comprehensive specialty-specific agentic AI platform for patient engagement, announces its inaugural customer summit, Assort Ascend. In an effort to turn ideas into real-world impact and continue to...

Assort Health Announces Inaugural Assort Ascend Customer Summit to Support Healthcare Leaders in Navigating AI Agent Transformation for Patient Engagement and Provider Operations
LCMC Health in Louisiana Partners with Care-at-Home Provider to Improve Patient Outcomes and Care

As part of its commitment to providing the best possible care for every person and parish in Louisiana and beyond, University Medical Center | LCMC Health will now offer high-acuity home-based care through myLaurel, an...

LCMC Health in Louisiana Partners with Care-at-Home Provider to Improve Patient Outcomes and Care
Olympus Announces Distribution Partnership with MacroLux Medical for Single-Use Urology Products

Olympus Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today an exclusive global distribution agreement with MacroLux Medical Technology...

Olympus Announces Distribution Partnership with MacroLux Medical for Single-Use Urology Products
Elevate Health Technologies Partners with D2 Solutions, Accelerating Patient Access Through Advanced Prior Authorization Technology

Elevate Health Technologies, a leading healthcare technology company delivering innovative solutions to healthcare providers, patients, pharmaceutical manufacturers and payors, today announced a strategic collaboration...

Elevate Health Technologies Partners with D2 Solutions, Accelerating Patient Access Through Advanced Prior Authorization Technology
Alma, a Sisram Medical Company, Announces Strategic Collaboration with Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence

Sisram Medical (1696.HK), a global leading innovator and provider of holistic medical aesthetic solutions, today announced a strategic collaboration between its subsidiary Alma, a global leader in energy-based medical and...

Alma, a Sisram Medical Company, Announces Strategic Collaboration with Celebrity Skin Expert Nurse Jamie to Expand Global Consumer Presence
Former U.S. Federal CIO Joins Nox Health Board, Bringing Proven Government Leadership to Drive Healthcare Innovation and Cost Savings

Nox Health, the global leader in sleep care management solutions, diagnostic technologies, and prescription digital therapeutics, announced the appointment of Clare Martorana, former Federal Chief Information Officer of...

Former U.S. Federal CIO Joins Nox Health Board, Bringing Proven Government Leadership to Drive Healthcare Innovation and Cost Savings
FLEX Vessel Prep™ System Spotlighted for Clinical Outcomes, Staff Efficiency Gains, and Real-World Physician Experience in the Journal of Vascular Access, Vascular News, and Endovascular Today

VentureMed Group, Inc., a privately held leader in medical device innovations for arteriovenous (AV) access and peripheral arterial disease (PAD), was recently featured in a published study on the outcomes of FLEX VP + DCB...

FLEX Vessel Prep™ System Spotlighted for Clinical Outcomes, Staff Efficiency Gains, and Real-World Physician Experience in the Journal of Vascular Access, Vascular News, and Endovascular Today
Ultrasound AI Secures New U.S. Patent for AI-Driven Clinical Value Determination, Expanding Global Patent Portfolio

Ultrasound AI™, Inc., a pioneer in artificial intelligence for medical imaging, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,369,883, "Artificial Intelligence System for...

Ultrasound AI Secures New U.S. Patent for AI-Driven Clinical Value Determination, Expanding Global Patent Portfolio
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced an advanced pharmacogenomic (PGx) laboratory test service designed to help providers understand the patient's...

Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
NEURIVA® LAUNCHES NEW MEMORY 3D FORMULA TO SUPPORT THE THREE DIMENSIONS OF MEMORY

Neuriva, a leading brain health supplement brand by Reckitt, proudly announces the launch of its most revolutionary innovation to date: Neuriva Memory 3D, a groundbreaking formula with ingredients designed to support three...

NEURIVA® LAUNCHES NEW MEMORY 3D FORMULA TO SUPPORT THE THREE DIMENSIONS OF MEMORY
Crossroads Treatment Centers Publishes Inaugural Annual Outcomes Report

Crossroads Treatment Centers (Crossroads), a leading national provider of comprehensive, evidence-based care for people affected by substance use disorders (SUDs), released their inaugural Annual Outcomes Report,...

Crossroads Treatment Centers Publishes Inaugural Annual Outcomes Report
AEYE Health Announces Yonatan Raz-Fridman as Chief Business Officer to Propel AEYE-DS U.S. Market Expansion

AEYE Health, the leader in AI-powered retinal diagnostics, announces the appointment of Yonatan Raz-Fridman as its Chief Business Officer. Raz-Fridman is a visionary entrepreneur and technology executive, bringing...

AEYE Health Announces Yonatan Raz-Fridman as Chief Business Officer to Propel AEYE-DS U.S. Market Expansion
Exxat and Powerback Rehab Partner to Modernize Clinical Education and Strengthen the Therapy Workforce

Exxat proudly announces its partnership with Powerback Rehab, a recognized leader in post-acute and rehabilitation services operating in over 1,200 locations across 40 states and growing. This collaboration aims to enhance...

Exxat and Powerback Rehab Partner to Modernize Clinical Education and Strengthen the Therapy Workforce
What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

In today's evolving health care environment, payers are under pressure to manage the rising costs of specialty drugs as the prevalence of chronic diseases increases and an aging population has higher demand for...

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues
EQUASHIELD® Launches CellSHIELD®: A New Era in Cell and Gene Therapy Manufacturing

EQUASHIELD®, a global leader in healthcare innovation, proudly announces the launch of CellSHIELD®, a groundbreaking device designed to transform cell and gene therapy manufacturing. Building on its proven expertise in...

EQUASHIELD® Launches CellSHIELD®: A New Era in Cell and Gene Therapy Manufacturing
Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an...

Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Novavax, Inc. (Nasdaq: NVAX) today announced a milestone payment* from Takeda has been triggered by regulatory approval for Novavax's COVID-19 vaccine Nuvaxovid® Intramuscular Injection 1 mL formulated to target...

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
TYBR Health Enrolls First Patients in Clinical Trial of B3 GEL™ System in Tendon Surgery

TYBR Health today announced the enrollment of the first patients in an Australian clinical trial evaluating the B3 GEL™ System in flexor and extensor tendon tenolysis procedures. The study is part of the company's...

TYBR Health Enrolls First Patients in Clinical Trial of B3 GEL™ System in Tendon Surgery
Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses
HOYA Vision Care Launches New Stock Lens Outlet for ECPs

Ophthalmic lens technology leader HOYA Vision Care announced today the launch of its new stock lens outlet, LensesByHOYA.us.  The new site provides customers who have in-office finishing capabilities the opportunity to...

HOYA Vision Care Launches New Stock Lens Outlet for ECPs
Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States

Sentec, a global leader in non-invasive patient monitoring, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LuMon™ Electrical Impedance Tomography (EIT) system for...

Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States
AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS)

AL-S Pharma today announced positive topline results from the Phase 2 clinical study evaluating AP-101, a potential first-in-class, disease-modifying treatment for amyotrophic lateral sclerosis (ALS). AP-101 is a...

AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS)
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancers

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to olomorasib, in combination with anti-PD-1 therapy KEYTRUDA (pembrolizumab),...

Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancers
Northwestern Mutual Recognizes Sept. 4 as National "goldeNMoments Day" to Shine a Light on Childhood Cancer Awareness Month

Childhood cancer is the leading cause of death by disease among children in the United States, yet many standard treatments used today were approved more than 30 years ago.1 However, with newer technology and science,...

Northwestern Mutual Recognizes Sept. 4 as National "goldeNMoments Day" to Shine a Light on Childhood Cancer Awareness Month
Armor Health Enhances its Services Partnership with Erie County to include Mental Health and Drug & Alcohol Programming

The Erie County Prison and their correctional healthcare partner, Armor Health (ArmorHealthcare.com), are pleased to announce the expansion of Medical services to include Mental Health services and Drug and Alcohol...

Armor Health Enhances its Services Partnership with Erie County to include Mental Health and Drug & Alcohol Programming
Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the company will deliver a total of 11 presentations, including clinical data on the selective orexin 2 receptor agonist (OX2R) E2086...

Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today...

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
SortPak Rx, Inc. Ranks Among Nation's Fastest-Growing Companies on the 2025 Inc. 5000 List

SortPak Rx, Inc., a trailblazer in technology-driven healthcare solutions, proudly announces its inclusion on the 2025 Inc. 5000 list of America's Fastest-Growing Private Companies, ranking #308 nationwide. This...

SortPak Rx, Inc. Ranks Among Nation's Fastest-Growing Companies on the 2025 Inc. 5000 List
Apex Dental Partners Named to Inc. 5000 List for Seventh Consecutive Year

Apex Dental Partners, the premier partnership choice for dentists, is proud to announce its inclusion on the Inc. 5000 list of the fastest-growing private companies in America for the seventh consecutive year. This rare...

Apex Dental Partners Named to Inc. 5000 List for Seventh Consecutive Year
Pure Strategies Releases New Report: Realizing Sustainable Packaging - The Next Era of Packaging

Pure Strategies, a sustainability consulting firm empowering brands and retailers to realize meaningful environmental and social improvement, has released a new report: Realizing Sustainable Packaging - The Next Era of...

Pure Strategies Releases New Report: Realizing Sustainable Packaging - The Next Era of Packaging
AYA Skin is coming to New York

Leading medical aesthetics provider, AYA Skin, has announced its expansion into New York, unifying with Park Avenue Medical Spa to deliver cutting-edge treatments and curated care.

AYA Skin is coming to New York
QC Kinetix Relaunches Strategic Franchise Expansion Following Comprehensive Brand Transformation

QC Kinetix, the largest regenerative medicine franchise in North America, officially relaunches its national franchise development initiative. The relaunch follows a year-long comprehensive brand transformation that...

QC Kinetix Relaunches Strategic Franchise Expansion Following Comprehensive Brand Transformation
MyOme Expands Proactive Health Portfolio with Launch of Type 2 Diabetes Integrated Polygenic Risk Score (iPRS)™

MyOme, a leading clinical whole genome testing and polygenic risk modelling (PRS) company, today announced the launch of its Type 2 Diabetes (T2D) Integrated Polygenic Risk Score™ (iPRS). The new report, available as part...

MyOme Expands Proactive Health Portfolio with Launch of Type 2 Diabetes Integrated Polygenic Risk Score (iPRS)™
Propedix Launches Dryello™, the First-Ever Dry Stick Antifungal for Athlete's Foot

Propedix, an innovator in anti-infective topical dermatology treatments, announces the launch of Dryello™ (tolnaftate 1%), a breakthrough over-the-counter antifungal treatment for Athlete's Foot (tinea pedis)....

Propedix Launches Dryello™, the First-Ever Dry Stick Antifungal for Athlete's Foot
Rightway Launches 2025 Rebrand, Marking a New Era in Healthcare Transformation

Rightway, the most transparent and member-focused pharmacy benefit manager (PBM) and personalized care navigation company, today unveiled its rebrand. The rebrand reflects Rightway's evolution from its earlier era as a...

Rightway Launches 2025 Rebrand, Marking a New Era in Healthcare Transformation
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

Illumina Inc. (NASDAQ: ILMN) today announced the launch of Illumina Protein Prep, an assay introducing superior performance for next-generation sequencing (NGS) based proteomics discovery at scale. Illumina Protein Prep ...

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Tobin Scientific Strengthens Leadership Team with Promotion of Julia Bushell to SVP, Quality and Regulatory Affairs

Tobin Scientific, a premier provider of cGMP storage, cold chain services, and specialized logistics for the life sciences industry, is pleased to announce the promotion of Julia Bushell to Senior Vice President (SVP) of...

Tobin Scientific Strengthens Leadership Team with Promotion of Julia Bushell to SVP, Quality and Regulatory Affairs
Qualia Life Sciences Achieves 2025 INC. 5000 List Of America's Fastest-Growing Private Companies For Third Time

Qualia Life Sciences, a supplement company known for breakthrough formulations , just achieved the 2025 Inc. 5000 nearly a decade after its founding due to remarkable recent growth. The Inc. 5000 is a prestigious annual...

Qualia Life Sciences Achieves 2025 INC. 5000 List Of America's Fastest-Growing Private Companies For Third Time
Orca Dental AI Partners with West Coast Dental to Revolutionize Radiographic Workflow for Multi-Location DSOs

Orca Dental AI, the leading provider of cloud-based, AI-powered dental imaging solutions, is proud to announce a strategic partnership with West Coast Dental, one of the fastest-growing Dental Service Organizations (DSOs)...

Orca Dental AI Partners with West Coast Dental to Revolutionize Radiographic Workflow for Multi-Location DSOs
Acurx Pharmaceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Closing Bid Price and Stockholder Equity Rules

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced that it had...

Acurx Pharmaceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Closing Bid Price and Stockholder Equity Rules
Visibly Acquires Easee, Driving Growth of Digital Eye Care Across U.S. and European Markets

Visibly, a digital health pioneer and developer of the world's first FDA-cleared online visual acuity test, announces the strategic acquisition of Easee, a European leader in digital eye care. This acquisition...

Visibly Acquires Easee, Driving Growth of Digital Eye Care Across U.S. and European Markets
Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs

Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the closing of a $59 million series B financing. The round was co-led by Novalis and...

Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs
Coya Therapeutics to Participate at Upcoming September Investor Conferences

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative...

Coya Therapeutics to Participate at Upcoming September Investor Conferences
Schivo Acquires Mecaplast SA

Strategic Acquisition Expands Schivo's in Precision Plastics, Metal and Ceramic Injection Molding Capabilities for MedTech and Life Sciences

Schivo Acquires Mecaplast SA
Jaeger™ Medical Opens U.S. Operations Facility in Moreno Valley, California

MORENO VALLEY, Calif., Sept. 3, 2025 /PRNewswire/ - Jaeger™ Medical, a global leader in respiratory diagnostic products, is proud to announce the opening of its new U.S. operations facility in Moreno Valley, California....

Jaeger™ Medical Opens U.S. Operations Facility in Moreno Valley, California
AblePay Health Named to Inc. 5000 for Fourth Consecutive Year

AblePay Health, a leader in patient financial engagement and healthcare payments, has been recognized for the fourth straight year on the Inc. 5000 list of America's fastest-growing private companies. In the 2025...

AblePay Health Named to Inc. 5000 for Fourth Consecutive Year
AliveDx announces U.S. Food and Drug Administration (FDA) 510(k) submission for its MosaiQ AiPlex® Vasculitis (VAS) assay.

AliveDx, the global in-vitro diagnostics company that aims to transform patient care, today announces that it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ...

AliveDx announces U.S. Food and Drug Administration (FDA) 510(k) submission for its MosaiQ AiPlex® Vasculitis (VAS) assay.
Members and Leaders of HFSA to be Recognized at the 2025 Annual Scientific Meeting in Minneapolis, MN

The Heart Failure Society of America (HFSA) announced the slate of 2025 HFSA Award recipients who will be recognized at the HFSA Annual Scientific Meeting 2025, September 26-29 in Minneapolis, MN

Members and Leaders of HFSA to be Recognized at the 2025 Annual Scientific Meeting in Minneapolis, MN
Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®

CVS Health® (NYSE: CVS) today announced that updated 2025-2026 flu vaccines are available at CVS Pharmacy® and MinuteClinic® locations nationwide. According to the Centers for Disease Control and Prevention (CDC), annual...

Updated flu vaccinations now available at CVS Pharmacy® and MinuteClinic®
Brainomix Stroke AI Software Hailed as ?Revolutionary,' Helping More Patients Fully Recover

Brainomix, a global leader and pioneer of AI-powered imaging tools in stroke and lung fibrosis, has garnered widespread media attention1 this week following a renewed focus on the impact of its Brainomix 360 Stroke...

Brainomix Stroke AI Software Hailed as ?Revolutionary,' Helping More Patients Fully Recover
U.S. Anesthesia Partners Hosts Unique Future Leaders in Anesthesia Conference

U.S. Anesthesia Partners, Inc. (USAP), will hold its third-annual Future Leaders in Anesthesia (FLA) conference at the Hotel Van Zandt in Austin, Texas, from Sept. 12-14. The conference will coach future anesthesiologists...

U.S. Anesthesia Partners Hosts Unique Future Leaders in Anesthesia Conference
Global Bio Conference 2025 kicks off in Seoul, charting biotech's future

This is an article published in The Korea Herald:

Global Bio Conference 2025 kicks off in Seoul, charting biotech's future
Apnimed to Highlight AD109 and the Burden of Obstructive Sleep Apnea (OSA) at World Sleep Congress 2025

Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drugs that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today...

Apnimed to Highlight AD109 and the Burden of Obstructive Sleep Apnea (OSA) at World Sleep Congress 2025
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers

Allergan Aesthetics, an AbbVie company, has launched the "Naturally You with Injectable Hyaluronic Acid Fillers" campaign, aimed to providing clear, factual education about HA injectable fillers. This initiative focuses on...

Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers
Andelyn Biosciences and Tern Therapeutics Partner for Late-Stage Process Performance Qualification (PPQ) Manufacturing of AAV Gene Therapy for the Treatment of CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Tern Therapeutics (Tern) to perform late-stage Process...

Andelyn Biosciences and Tern Therapeutics Partner for Late-Stage Process Performance Qualification (PPQ) Manufacturing of AAV Gene Therapy for the Treatment of CLN2 Batten Disease
SPS Expands Philips SpeechLive with Ambient Medical AI Documentation, Powered by Corti

Speech Processing Solutions (SPS), the global leader behind Philips SpeechLive, today announced a strategic partnership with Corti, the specialized AI infrastructure company for healthcare, to introduce ambient clinical...

SPS Expands Philips SpeechLive with Ambient Medical AI Documentation, Powered by Corti
VirtuaLensTM Launches Immersive Virtual Reality IOL Simulator, Transforming Cataract Patient Education and Lens Selection

VirtuaLensTM, a pioneering eye care medical technology company, today announced the launch of the first-of-its-kind Immersive IOL Simulator - a virtual reality (VR) platform that enables cataract patients to explore and...

VirtuaLensTM Launches Immersive Virtual Reality IOL Simulator, Transforming Cataract Patient Education and Lens Selection
University Lab Partners Opens Applications for the I-CREATE Program -- Offering up to $200K in Funding and a $50K Cash Prize

University Lab Partners (ULP), in partnership with the Biomedical Advanced Research and Development Authority (BARDA), today announced that applications are now open for the I-CREATE program and accelerator. Together,...

University Lab Partners Opens Applications for the I-CREATE Program -- Offering up to $200K in Funding and a $50K Cash Prize
DeepQure Strengthens Clinical Leadership with Former SoniVie Executive Appointment

DeepQure, a company pioneering a paradigm shift in hypertension treatment, today announced the appointment of Jason G. Jones as Global Vice President of Clinical & Regulatory Affairs.

DeepQure Strengthens Clinical Leadership with Former SoniVie Executive Appointment
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that Eisai has...

Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection

WoundGenex, the industry leader in wound care revenue cycle and practice management solutions, and Shoreline Medical Administration, a premier healthcare support partner specializing in safeguarding Medicare reimbursements...

WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection
Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai

Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2025 Arablab Live tradeshow and conference, taking place in Dubai from September 23-25.

Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of...

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
/U P D A T E -- Eisai Inc./

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai")  and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen") announced today that the U.S. Food and Drug...

/U P D A T E -- Eisai Inc./
Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device Under Awake Sedation

Intrinsic Therapeutics, Inc., a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by reducing reoperations for reherniations by 81%* with its...

Intrinsic Therapeutics Announces the First Implantation of the Barricaid® Annular Closure Device Under Awake Sedation
Asieris Pharmaceuticals Releases 2025 Semi-Annual Report with Sustained Commercial Momentum and Breakthrough Innovation Poised for Launch

Asieris Pharmaceuticals today released its 2025 Semi-Annual Report, highlighting strong growth momentum. The company's Commercial Operation 2.0 has begun to deliver results, with sales rising steadily and first-half...

Asieris Pharmaceuticals Releases 2025 Semi-Annual Report with Sustained Commercial Momentum and Breakthrough Innovation Poised for Launch
Meadows Behavioral Healthcare Announces New Chief Medical Officer Dr. Aaron Wilson

Meadows Behavioral Healthcare (MBH), an industry leader in specialized behavioral health treatment, have welcomed Dr. Aaron Wilson, as their new Chief Medical Officer. Dr. Wilson, a double board-certified psychiatrist and...

Meadows Behavioral Healthcare Announces New Chief Medical Officer Dr. Aaron Wilson
Dr. Sunil Chandran Rejoins Amyris as Chief Technology Officer to Meet Growing Customer Demand for Innovative and Renewable Biological Chemistry

Amyris, Inc. is pleased to announce the appointment of Dr. Sunil Chandran as Chief Technology Officer.

Dr. Sunil Chandran Rejoins Amyris as Chief Technology Officer to Meet Growing Customer Demand for Innovative and Renewable Biological Chemistry
RareMed Announces Expansion of Relationship with PTC Therapeutics

RareMed Solutions®, the nation's leader in patient support services for complex therapies, is proud to announce an expansion of its relationship with PTC Therapeutics™ with the launch of non-commercial pharmacy...

RareMed Announces Expansion of Relationship with PTC Therapeutics
Adena cardiologist recognized internationally as one of interventional cardiology's "30 in Their 30s"

Adena Heart and Vascular Institute interventional cardiologist Hafeez Hassan, MD has been named to the prestigious "30 in Their 30s" list by the Society for Cardiovascular Angiography & Interventions (SCAI).

Adena cardiologist recognized internationally as one of interventional cardiology's "30 in Their 30s"
E2 (Endovascular Engineering, Inc.) Appoints Justin Farry as Chief Financial Officer to Support Next Phase of Growth

E2 (Endovascular Engineering, Inc.) a medical device company advancing endovascular therapies for the treatment of venous thrombo-embolism (VTE), today announced the appointment of Justin Farry as its new Chief Financial...

E2 (Endovascular Engineering, Inc.) Appoints Justin Farry as Chief Financial Officer to Support Next Phase of Growth
WelbeHealth Expands PACE Access in Sacramento and San Bernardino Counties

Today, the physician-led senior health services provider WelbeHealth announced the opening of two new centers in Elk Grove (Sacramento County) and San Bernardino (San Bernardino County). The launches reflect...

WelbeHealth Expands PACE Access in Sacramento and San Bernardino Counties
New ACS Prostate Cancer Statistics Report: Late-Stage Incidence Rates Continue to Increase Rapidly as Mortality Declines Slow

Today, the American Cancer Society (ACS) released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate cancer incidence rates...

New ACS Prostate Cancer Statistics Report: Late-Stage Incidence Rates Continue to Increase Rapidly as Mortality Declines Slow
Nuclear Care Partners Launches Care+ Kidney, the First Comprehensive In-Home Kidney Care Program Covered Under EEOICPA

Nuclear Care Partners, the leading provider of specialized in-home care for former Department of Energy (DOE) and nuclear weapons workers, is proud to announce the launch of Care+ Kidney, designed specifically for former...

Nuclear Care Partners Launches Care+ Kidney, the First Comprehensive In-Home Kidney Care Program Covered Under EEOICPA
GeneseeqPrime® Gains FDA 510(k) Clearance

With FDA., CE-IVD, and NMPA approvals, the comprehensive tumor profiling kit enables decentralized, standardized oncology testing worldwide

GeneseeqPrime® Gains FDA 510(k) Clearance
Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress

Evommune, Inc., a clinical stage biotechnology company discovering and developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced that a full data set from the Phase 2 trial...

Evommune Announces Late-Breaker Presentation of Phase 2 Data for EVO756 in Chronic Inducible Urticaria at Upcoming European Academy of Dermatology and Venereology (EADV) 2025 Congress
Piedmont Heart Institute Performs Record Number of Heart Transplants

Piedmont Heart Institute set a new organizational record in 2024 by performing 103 heart transplants at Piedmont Atlanta Hospital. Since starting in 2012, the heart transplant program has performed more than 375 heart...

Piedmont Heart Institute Performs Record Number of Heart Transplants
Wonderfeel's Clinical Brief Gets Published as Its Flagship Formula Earns Wellness From Within Award

Wonderfeel Biosciences, a frontrunner in wellness biosciences, has achieved two milestone-marking moments in its mission to bring longevity science to everyday wellness. The first is the publication of its peer-reviewed...

Wonderfeel's Clinical Brief Gets Published as Its Flagship Formula Earns Wellness From Within Award
Depend® Teams Up with Ken Griffey Jr. & Sr. to Inspire Early Detection and Open Conversation Around Prostate Cancer

Prostate cancer affects one in eight men1 and can lead to bladder leaks, yet remains a topic many still find hard to discuss. This Prostate Cancer Awareness Month, Depend® is continuing its multi-year mission to break the...

Depend® Teams Up with Ken Griffey Jr. & Sr. to Inspire Early Detection and Open Conversation Around Prostate Cancer